Heartworm Disease in Dogs: Medicines, Treatment Stages & Recovery

Heartworm disease in dogs is a preventable but potentially life-threatening infection caused by Dirofilaria immitis. Treatment is not simply a matter of giving a monthly preventive after a positive test. Established infection requires staging, exercise restriction, adulticide therapy and careful management of inflammation and complications. Medication choices depend on the dog’s disease burden and clinical status.

Dog outdoors during routine heartworm prevention and monitoring
Heartworm prevention and heartworm treatment are different: established disease requires a structured veterinary treatment plan.

This guide explains how heartworm disease develops, why prevention does not equal treatment, how melarsomine, doxycycline and macrocyclic lactones fit into management, why exercise restriction is essential, and what owners should know about testing, staging and recovery.

What heartworm disease is

Heartworm disease is caused by a mosquito-transmitted filarial parasite that matures into adult worms living primarily in the pulmonary arteries and sometimes the right side of the heart.

How dogs become infected

Mosquitoes ingest microfilariae from an infected animal and later transmit infective larvae to another dog during feeding.

Why direct dog-to-dog transmission does not occur

The parasite requires mosquito development between hosts.

Why geography matters

Heartworm prevalence varies by climate and mosquito populations, but infected dogs and mosquitoes can occur outside traditional high-risk areas.

Why travel changes risk

A dog living in a low-prevalence region can be exposed during travel to an endemic area.

Why prevention is recommended broadly

Consistent prophylaxis is far safer and less expensive than treating established adult infection.

Common preventive drug classes

Macrocyclic lactones such as ivermectin, milbemycin, moxidectin and selamectin are used in heartworm prevention products.

Ivermectin

Ivermectin is used at low preventive exposures in many heartworm products. See Ivermectin for Dogs.

Milbemycin

Milbemycin oxime is used in oral preventives and combination parasite products. See Milbemycin for Dogs.

Moxidectin

Moxidectin appears in topical and long-acting injectable preventive products. See Moxidectin for Dogs.

Selamectin

Selamectin is a topical macrocyclic lactone used for heartworm prevention and selected parasites. See Selamectin for Dogs.

Why prevention is not adulticide treatment

Monthly preventives primarily target larval stages. They do not provide the same controlled elimination of adult worms as melarsomine-based treatment.

Why “slow kill” is not the preferred standard

Allowing adult worms to die gradually over many months prolongs pulmonary vascular damage and can contribute to resistance selection.

Why a positive heartworm test needs staging

The veterinarian assesses clinical signs, chest radiographs, bloodwork and sometimes additional testing to estimate disease severity.

Antigen testing

Heartworm antigen tests detect proteins produced mainly by adult female worms.

Why antigen testing can miss some infections

Low worm burden, immature infection or all-male infection can reduce detectability.

Microfilaria testing

Looking for circulating microfilariae provides additional information and helps identify transmission potential.

Why both tests can be useful

Antigen and microfilaria testing answer different questions and together provide a more complete picture.

Why annual testing is still recommended on prevention

Missed doses, administration errors, product failure or lapses can occur, and early detection simplifies management.

Clinical signs

Dogs may cough, tire easily, lose weight, breathe rapidly or show reduced exercise tolerance.

Why some infected dogs have no signs

Early or low-burden disease can be clinically silent.

Why exercise intolerance matters

Adult worms damage pulmonary arteries and increase cardiopulmonary stress during activity.

Why coughing occurs

Pulmonary vascular inflammation and associated lung changes can produce cough.

Why weight loss can occur

Chronic cardiopulmonary disease increases metabolic stress and can reduce appetite or activity.

Caval syndrome

Severe worm burden can obstruct blood flow through the right heart, causing collapse, weakness, dark urine and life-threatening circulatory compromise.

Why caval syndrome is an emergency

Mechanical removal of worms may be required urgently before standard adulticide treatment can proceed.

Why exercise restriction is essential

Physical activity increases blood flow through damaged pulmonary arteries and raises the risk of severe complications as worms die.

Why “the dog feels fine” does not make exercise safe

Clinical appearance does not reflect the full degree of pulmonary vascular damage.

When exercise restriction begins

Restriction generally starts once infection is diagnosed and continues throughout treatment and recovery according to the veterinarian’s plan.

What exercise restriction looks like

Leash walks for toileting, avoidance of running and controlled indoor activity are typical components, though the exact plan varies by severity.

Why mental enrichment helps

Food puzzles, scent games and calm training can reduce frustration while physical activity is limited.

Doxycycline

Doxycycline is commonly used in heartworm treatment to target Wolbachia bacteria associated with the parasite. See Doxycycline for Dogs.

Why Wolbachia matters

These intracellular bacteria contribute to parasite biology and inflammatory responses when worms die.

Why doxycycline is not a substitute for adulticide treatment

It supports the protocol but does not replace melarsomine’s adult-worm killing role.

Macrocyclic lactone prevention during treatment

Preventive medication is continued or started as directed to eliminate susceptible larval stages and prevent new infection.

Why microfilariae need consideration

Killing circulating microfilariae can trigger reactions in heavily infected dogs, so the veterinarian may monitor carefully.

Melarsomine

Melarsomine dihydrochloride is the adulticide drug used to kill mature heartworms in dogs.

Why a multi-injection protocol is used

The standard three-dose protocol improves efficacy and is generally preferred over two injections alone.

Why injections are given in deep epaxial muscles

Melarsomine is administered intramuscularly according to a specific technique and schedule.

Why injection-site pain occurs

Soreness, stiffness or reluctance to move can occur after treatment.

Why pain control is planned

Veterinarians may use appropriate analgesia around adulticide injections while avoiding unsafe NSAID combinations or other risks.

Why dead worms are dangerous

As adult worms die, fragments travel through the pulmonary arteries and can trigger inflammation and thromboembolic complications.

Pulmonary thromboembolism

Clotting and inflammatory reactions around dying worms can impair lung circulation and cause coughing, breathing difficulty or collapse.

Why exercise restriction is especially important after melarsomine

Higher activity increases pulmonary blood flow and may worsen embolic complications.

Why coughing after treatment matters

Mild cough can occur, but increasing cough, breathing difficulty, fever, weakness or collapse should be reported immediately.

Why corticosteroids may be used

Prednisone can help control inflammation associated with worm death in selected protocols.

Why prednisone is not the heartworm cure

It controls inflammatory complications but does not kill adult worms.

Why antibiotics beyond doxycycline are not routinely needed

Heartworm disease is parasitic, not a conventional bacterial infection, even though Wolbachia-targeted doxycycline is part of treatment.

Why NSAIDs are not the main treatment

Pain relief does not address the parasite burden or pulmonary inflammation appropriately on its own.

Why chest radiographs matter

They help assess pulmonary arteries, lung changes and heart size before treatment.

Why bloodwork matters

Baseline organ function helps identify concurrent disease and treatment risk.

Why urinalysis may matter

Proteinuria and kidney effects can occur in chronic heartworm disease.

Why echocardiography may be used

Ultrasound can assess worm burden, right-heart changes and severe disease in selected patients.

Why stage influences treatment

Dogs with severe cardiopulmonary compromise may need stabilization before adulticide therapy.

Why weight matters

Melarsomine and several supportive medications are dosed by weight, so current measurement is important.

Why obesity can complicate treatment

Excess weight increases cardiopulmonary demand and can make exercise restriction and injection technique more difficult.

Why underweight dogs need nutritional support

Chronic disease can cause muscle loss and poor body condition, which may affect recovery.

Why heartworm treatment takes months

The protocol includes pretreatment, adulticide injections, recovery periods and follow-up testing.

Why owners should expect multiple visits

Staging, injections, monitoring and post-treatment testing cannot be completed in a single appointment.

Why a negative antigen test is not immediate proof of cure

Follow-up testing is timed after treatment because residual antigen can persist and adult worms need time to clear.

Why prevention continues after treatment

A successfully treated dog can be reinfected by mosquitoes if prevention stops.

Why missed preventive doses matter

A lapse can allow new larvae to mature. Contact the veterinarian rather than doubling the next dose.

Why regional mosquito season is not a perfect guide

Indoor mosquitoes, changing climate and travel can extend exposure beyond traditional seasonal assumptions.

Why year-round prevention simplifies adherence

Consistent monthly or scheduled prevention reduces gaps caused by uncertain season timing.

Why ABCB1/MDR1 sensitivity matters

Some herding breeds have increased sensitivity to high doses of certain macrocyclic lactones, though labeled heartworm-preventive doses are far lower than many off-label exposures.

Why breed alone is not enough

Genetic testing gives more specific information than assuming every Collie or Australian Shepherd carries a variant.

Why high-dose livestock ivermectin is not a substitute for prevention

Concentration and safety are very different from labeled canine products.

Why prevention products should not be mixed casually

Using multiple preventives can duplicate active ingredients or increase adverse effects.

Why travel history matters

Dogs moving between regions may need prevention plans adjusted for heartworm and other parasites.

Why mosquito control is not enough

Repellents and environmental control reduce exposure but cannot replace effective chemoprophylaxis.

Why heartworm-positive dogs should not be exercised heavily before treatment

Pulmonary vascular disease is already present before adulticide therapy begins.

Why coughing during exercise restriction should be reported

Worsening respiratory signs can signal disease progression or treatment complications.

Why emergency signs include collapse and breathing difficulty

These can indicate thromboembolism, right-heart failure or caval syndrome.

Why dark urine can be significant

Hemoglobinuria can occur with caval syndrome and severe intravascular hemolysis.

Why abdominal swelling can occur

Right-sided heart failure can cause ascites in advanced disease.

Why treatment cost should not lead to improvised slow-kill regimens

If finances are a barrier, discuss options with the veterinarian rather than replacing recommended treatment with unsupervised preventive-only strategies.

Why shelters need structured protocols

High-prevalence populations require testing, prevention and treatment plans that account for logistics without compromising safety.

Why adoption after diagnosis is still possible

Many heartworm-positive dogs recover well when treated appropriately and activity is controlled during the dangerous period.

What owners should track during treatment

  • cough frequency;
  • breathing effort;
  • energy and exercise tolerance;
  • appetite;
  • injection-site pain;
  • fever;
  • medication adherence;
  • strict activity restriction.

How heartworm disease connects to DogMedsHub

This page links to Parasite & Heartworm Medicines, the main ivermectin, milbemycin, moxidectin, selamectin and doxycycline guides, and the MDR1 safety page rather than duplicating those medication entities.

Source context

The American Heartworm Society canine guidelines emphasize a structured protocol using macrocyclic lactone prevention, doxycycline, melarsomine adulticide therapy and strict exercise restriction rather than preventive-only “slow kill” approaches.

Why heartworm disease damages arteries before heart failure develops

Adult worms live mainly in pulmonary arteries, where they cause chronic inflammation, endothelial injury and narrowing long before obvious right-sided heart failure appears.

Why worm burden is only part of severity

A dog with fewer worms can still have significant disease if activity level is high or pulmonary damage is severe.

Why small dogs can become very ill with fewer worms

Smaller pulmonary arteries mean each adult worm occupies proportionally more vascular space.

Why active dogs can show more severe consequences

Higher cardiac output increases blood flow through damaged pulmonary vessels and can accelerate clinical deterioration.

Why exercise restriction begins immediately after diagnosis

Reducing pulmonary blood flow lowers stress on injured arteries before adulticide treatment even starts.

Why confinement should be humane

Dogs still need toileting, enrichment and social contact. The goal is calm controlled activity, not isolation.

Why sedating or anxiolytic medication may occasionally help restriction

Very active dogs may need veterinarian-directed behavior support to remain safely confined during treatment.

Why trazodone or gabapentin may sometimes be considered

These medicines can help selected dogs tolerate restricted activity, but sedation and interactions should be planned rather than improvised.

Why cough suppressants are not routine treatment

Cough can reflect pulmonary inflammation and disease progression. Suppressing it without assessing the cause may hide important changes.

Why antibiotics other than doxycycline are not the target

The central bacterial target in standard heartworm protocols is Wolbachia, not a conventional lung infection.

Why doxycycline duration is planned carefully

The goal is to reduce Wolbachia burden before adult worms are killed, which can decrease inflammatory complications.

Why missed doxycycline doses should be discussed

Repeated missed doses can reduce protocol effectiveness. Do not double automatically.

Why GI upset from doxycycline matters

Nausea or esophageal irritation can undermine adherence. Food timing or formulation may need adjustment.

Why melarsomine is not given at home

It is a prescription injectable requiring deep intramuscular administration, dose calculation and post-injection monitoring.

Why the three-dose protocol improves efficacy

Staging injections increases adult-worm kill while allowing the dog to recover between treatment phases.

Why injection pain can be substantial

The deep lumbar injection can cause soreness, stiffness and reluctance to move for several days.

Why local swelling should be monitored

Severe swelling, discharge or worsening pain at the injection site should be reported.

Why fever after adulticide treatment matters

Fever can accompany inflammatory complications and should be interpreted with cough, breathing effort and overall condition.

Why breathing rate at rest is useful

Owners can learn the dog’s normal sleeping respiratory rate and report sustained increases during recovery.

Why coughing that suddenly worsens is important

It can signal pulmonary thromboembolism or inflammation from dying worms.

Why blood in the cough is an emergency sign

Hemoptysis can indicate severe pulmonary injury and requires prompt evaluation.

Why collapse during recovery is an emergency

Possible causes include embolism, severe cardiopulmonary compromise or caval syndrome.

Why right-heart failure can develop

Chronic pulmonary hypertension increases workload on the right side of the heart.

Why ascites can appear

Advanced right-sided heart failure can cause fluid accumulation in the abdomen.

Why liver enlargement can occur

Venous congestion from right-heart failure can enlarge the liver and contribute to abdominal discomfort.

Why echocardiography can visualize worms in severe cases

Adult heartworms may be seen within pulmonary arteries or the right heart when burden is high.

Why caval syndrome can require worm extraction

When worms obstruct blood flow through the tricuspid valve and vena cava, rapid mechanical removal may be lifesaving.

Why dark urine in caval syndrome is significant

Mechanical damage to red blood cells can produce hemoglobinuria.

Why anemia can occur

Hemolysis and chronic disease can lower red blood cell mass in severe infection.

Why platelet counts can change

Inflammation and vascular injury can affect platelets and coagulation in advanced disease.

Why protein in urine matters

Immune-complex kidney disease can occur in chronic heartworm infection.

Why kidney health matters before treatment

Baseline renal function helps the veterinarian plan supportive care and interpret later changes.

Why liver health matters before treatment

Severe chronic disease can affect multiple organs, and baseline values help assess overall treatment risk.

Why chest radiographs may be repeated

They can document pulmonary changes and response when clinical signs worsen.

Why antigen tests are repeated months after treatment

Testing too soon can detect residual antigen or miss the full treatment outcome.

Why persistent antigen after treatment matters

It may indicate surviving adult worms or require additional interpretation and follow-up.

Why microfilaria testing after treatment matters

Persistent circulating microfilariae can indicate incomplete clearance and continued transmission potential.

Why prevention needs perfect adherence after recovery

Prior infection does not create immunity. A treated dog can become infected again.

Why monthly preventives should not be stopped during winter without guidance

Mosquito seasons are unpredictable, indoor exposure occurs and regional recommendations increasingly favor year-round prevention.

Why long-acting injectable prevention may help some households

Longer-duration products reduce monthly adherence burden but still require veterinary scheduling and appropriate testing.

Why oral prevention suits other households

Monthly oral products can combine heartworm protection with intestinal parasite coverage and are easy to document when given reliably.

Why topical prevention may suit pill-averse dogs

Selamectin or topical moxidectin combinations provide alternatives when oral administration is difficult.

Why product selection should consider all parasites

Flea, tick and intestinal parasite risks vary by geography and lifestyle, so a heartworm product may be chosen as part of a broader prevention plan.

Why MDR1 testing can clarify risk

Dogs with known ABCB1 variants may still safely receive labeled heartworm prevention, but high-dose macrocyclic-lactone exposure deserves special caution.

Why preventive dosing should never be improvised from livestock products

Concentrations are too easy to miscalculate and can cause serious neurologic toxicity.

Why shelters and rescues face special challenges

Unknown prevention history and high regional prevalence can create frequent positive tests, requiring structured protocols and careful exercise management.

Why newly adopted dogs should be tested

Prior prevention history may be incomplete or unreliable, especially after transport from endemic regions.

Why puppies need age-appropriate prevention

Products have minimum ages and weights, and young dogs can become infected if prevention is delayed too long.

Why prevention should begin before the first positive test is possible

Young infections may not yet produce detectable antigen, which is why prevention starts before adult worms mature.

Why travel history should be recorded for years

Heartworm maturation takes months, so an exposure during a previous trip may become detectable later.

Why coughing after exercise deserves attention even in a “healthy” dog

Exercise intolerance and cough can be early signs before dramatic illness develops.

Why a positive dog can still have a good prognosis

Many dogs recover well with structured treatment, strict activity restriction and consistent follow-up.

Why prognosis worsens with advanced disease

Pulmonary hypertension, right-heart failure, caval syndrome and organ injury increase treatment risk and recovery time.

Why owner adherence is part of treatment success

Giving medications correctly is only one piece; keeping the dog calm and attending scheduled injections and rechecks are equally important.

Why a written treatment calendar helps

Heartworm protocols span weeks to months and include doxycycline, prevention, melarsomine injections and follow-up testing. A calendar reduces missed steps.

Why emergency instructions should be visible

Owners should know which signs—collapse, severe breathing difficulty, coughing blood or marked weakness—require immediate care during recovery.

Medication guides linked to heartworm prevention

For preventive-drug details, see Ivermectin, Milbemycin, Moxidectin and Selamectin. These are prevention guides, not substitutes for the structured treatment plan required after a positive heartworm diagnosis.

This condition page owns disease staging, treatment sequence and recovery. The medication pages own product-specific prevention, dosing context and safety questions.

Last reviewed: October 2026. Educational information only; heartworm-positive dogs require veterinary staging and a structured treatment plan because adult-worm death can create serious cardiopulmonary complications.

Share